497-Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis
- G Yosipovitch (Author)
- PA Lio (Author)
- D Rosmarin (Author)
- M Casillas (Author)
- FE Yang (Author)
- CR Hu (Author)
- E Pierce (Author)
- Legat, F. (Author)
- JM Carrascosa (Author)
- H Crane (Author)
- L Boncompte (Author)
- S Stander (Author)
Activity: Talk, presentation or poster › Poster